Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1010 of 5804
-
New Game-Based therapy aims to stop muscle loss in hospitalized seniors
Disease control Recruiting nowThis study investigates a new training method designed to help older adults preserve their muscle strength during hospitalization. When older adults are admitted to the hospital and spend long periods in bed, their muscles can weaken very quickly. This condition is known as hospi…
Phase: PHASE2 • Sponsor: Vrije Universiteit Brussel • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New rapid test could slash unnecessary antibiotic use in ventilator pneumonia patients
Disease control Not yet recruitingThe objective of the study is to determine whether rapid multiplex PCR testing of respiratory samples can reduce exposure to broad-spectrum antibiotics in intensive care unit patients with suspected or confirmed ventilator-associated pneumonia, compared to standard diagnostic met…
Phase: NA • Sponsor: University Hospital, Geneva • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Heart valve patients may ditch blood thinners for simple aspirin
Disease control Recruiting nowThis trial is a multinational, multicenter, randomized, open-label, active-controlled clinical trial comparing the safety of aspirin versus vitamin K antagonists (warfarin) as oral antithrombotic therapy during the initial 6 months following tissue valve replacement (aortic or mi…
Phase: PHASE4 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug aims to quiet artery inflammation and prevent heart attacks
Disease control Recruiting nowThe main purpose of the study is to evaluate the efficacy of selnoflast compared with placebo in participants with atherosclerosis, at high-risk for major adverse cardiovascular event (MACE), who are currently on standard-of-care (SOC) therapy.
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Steam therapy for prostate cancer under Long-Term review
Disease control Recruiting nowThe purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive …
Sponsor: Francis Medical Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Experimental drug targets deadly brain virus in small trial
Disease control Recruiting nowBackground: Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal brain infection caused by the JC virus. The JC virus is common. More than half of adults have been exposed to it. Most people do not get sick from the JC virus, but in people with weakened imm…
Phase: PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New vaccine shows promise in early trial for tough cancers
Disease control Recruiting nowAdvanced solid tumors remain a major therapeutic challenge due to their complex heterogeneity and the immunosuppressive tumor microenvironment (TME). Although cancer vaccines are designed to induce long-lasting antitumor immunity, their efficacy is often limited by the TME's immu…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Cholesterol drug may boost immunotherapy in Hard-to-Treat stomach cancer
Disease control Not yet recruitingBackground: Gastric cancer remains a significant health burden globally, particularly in China, where the majority of patients present with advanced disease at diagnosis. While immune checkpoint inhibitors (ICIs) targeting PD-1 have revolutionized treatment for various malignanc…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to simplify care for patients with multiple leaky heart valves
Disease control Not yet recruitingAortic stenosis is a condition in which the aortic valve becomes narrow and does not open properly, making it harder for the heart to pump blood to the body. Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure commonly used to treat this condition, es…
Sponsor: Josep Rodes-Cabau • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can targeted electrical stimulation or task practice better restore leg movement after a stroke?
Disease control OngoingStroke-induced lower limb impairments severely inhibit functional independence and mobility in survivors. Inventive techniques like Synergy-Based Electrical Stimulation (SBES) and Task-Oriented Training (TOT) support favorable rehabilitation results based on Neuroplasticity. This…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Stroke survivors may walk better with muscle retraining device
Symptom relief Recruiting nowThis study will test the ability of myoelectric interface for neurorehabilitation (MINT) training to improve walking function.
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New antibody aims to tame rare bleeding disorder
Disease control Recruiting nowThis is a Phase 1/2, randomized, double-blind, placebo-controlled, first-in-human study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of subcutaneously administered DIAG723 in adult patients with hereditary hemorrhagic telangiectasia (HHT). The …
Phase: PHASE1, PHASE2 • Sponsor: Diagonal Therapeutics, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New targeted cancer drug enters first human tests
Disease control Not yet recruitingThis is a Phase I, multicenter, open-label clinical trial with dose escalation/dose expansion phases, designed to evaluate the safety, tolerability, pharmacokinetic/pharmacodynamic (PK/PD) profiles, and antitumor efficacy characteristics of HS-10587 in patients with MTAP-deleted …
Phase: PHASE1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Brain stimulation study seeks clues to lasting depression relief
Knowledge-focused Recruiting nowDespite advances in the effective treatment of major depressive disorder using repetitive transcranial magnetic stimulation (rTMS), the processes that determine a patient's response trajectory remain poorly understood. Currently, there are no validated clinical or neurophysiolog…
Sponsor: Hospital Center Guillaume Régnier • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Could an antidepressant ease long COVID fatigue?
Symptom relief Recruiting nowFatigue, cognitive problems, post-exertional malaise (PEM) and postural orthostatic tachycardia syndrome (POTS) are common and debilitating symptoms after COVID-19. The pathophysiology of post-COVID is not well understood and there is no established biomedical treatment. Treatmen…
Phase: PHASE3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Urine test may outsmart blood test for kidney rejection
Diagnosis CompletedKidney transplant rejection remains a significant challenge to long-term graft survival. While histological biopsy continues to be the gold standard for diagnosing rejection, noninvasive biomarkers such as donor-derived cell-free DNA (dd-cfDNA) have gained traction for their abil…
Sponsor: Virginia Commonwealth University • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
New drug combo aims to tackle Hard-to-Treat lymphoma
Disease control Recruiting nowThis study is to assess safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary efficacy of ARC-02.
Phase: PHASE1 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Ultrasound-Guided fluid removal may offer safer relief for overloaded kidneys
Disease control Recruiting nowThe purpose of this study is to evaluate whether a personalized, high-rate fluid removal strategy guided by ultrasound is as safe and effective as the standard fluid removal rate for patients with advanced kidney disease who are hospitalized due to severe fluid overload (congesti…
Phase: NA • Sponsor: Universidad Autonoma de Nuevo Leon • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can a common Weight-Loss pill help teens? new trial aims to find out
Disease control Recruiting nowPhITT is a Phase IIb, multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the efficacy and safety of phentermine (16 mg daily) in adolescents aged 12 to \<18 years with obesity. Conducted across approximately 10 sites within the IDeA States Pediatr…
Phase: PHASE2 • Sponsor: Russell McCulloh, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Triple threat: drug cocktail and precision radiation take on tough bile duct cancer
Disease control OngoingThis study aims to evaluate the safety and preliminary efficacy of anlotinib combined with cadonilimab and PULSAR in previously treated advanced unresectable or netastatic biliary tract cancer.
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC